Company Performance Metrics
- James Rodberg: Chief Financial Officer and TreasurerPast Role: Sight Sciences, VP Finance, Corporate Controller
- Matt Link: Chief Commercial OfficerPast Role: NuVasive, President
Sight Sciences is a medical device company that uses a computer-based device designed for the treatment of eye disease. Sight Sciences' devices and non-invasive dry eye products are used for glaucoma procedures or in combination with cataract surgery using the same clear corneal incision, assisting ophthalmologists and optometrists to address
the underlying physiology of ophthalmic disease.
The company's non-surgical Dry Eye product portfolio consists of TearCare which is now commercially available for both ophthalmologists and optometrists. TearCare is a software-controlled, wearable eyelid technology that delivers highly targeted and adjustable heat to the meibomian glands of the eyelids for conditions such as meibomian gland dysfunction and dry eye.
It was founded in 2011 and is headquartered in Menlo Park, California, United States.
